Calpinactam, a new anti-mycobacterial agent, produced by Mortierella alpina FKI-4905

Journal of Antibiotics

Volumn 63, Issue 4, 2010, Pages 183-186

  Koyama, Nobuhiro ^a   Kojima, Shigenobu ^a   Nonaka, Kenichi ^a   Masuma, Rokuro ^a   Matsumoto, Makoto ^b   Mura, Satoshi ^a   Tomoda, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Microbiological Research Institute   (Japan)

Author keywords

Anti mycobacterial peptide; Calpinactam; Fungal metabolite; Mycobactin; Tuberculosis

Indexed keywords

ANTIINFECTIVE AGENT; CALPINACTAM; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ISOLATION; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; MORTIERELLA ALPINA; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SOLVENT EXTRACTION; YEAST;

ANTITUBERCULAR AGENTS; CAPROLACTAM; DNA, BACTERIAL; DNA, RIBOSOMAL SPACER; HUMANS; MICROBIAL SENSITIVITY TESTS; MORTIERELLA; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; OLIGOPEPTIDES; RNA, RIBOSOMAL;

CORYNEBACTERINEAE; FUNGI; MORTIERELLA ALPINA; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; POSIBACTERIA;

EID: 77951719001     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2010.14     Document Type: Article

References (23)

1. Fukumoto, A. et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04- 0144. I. Taxonomy, fermentation, isolation and structural elucidation. J. Antibiot. 61, 1-6 (2008).
2. Fukumoto, A. et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04- 0144. II. Biological activities. J. Antibiot. 61, 7-10 (2008).
3. Iwatsuki, M. et al. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. I: taxonomy, fermentation, isolation and biological properties. J. Antibiot. 61, 222-229 (2008).
4. Iwatsuki, M. et al. Guadinomines, Type III secretion system inhibitors, produced by Streptomyces sp. K01-0509. II: physico-chemical properties and structure elucidation. J. Antibiot. 61, 230-236 (2008).
5. Fukuda, T., Hasegawa, Y., Sakabe, Y., Tomoda, H. & Omura, S. Citrinamides, new potentiators of antifungal miconazole activity, produced by Penicillium sp. FKI-1938. J. Antibiot. 61, 550-555 (2008).
6. NIAID's Tuberculosis Antimicrobial Acquisition & Coordinating Facility (TAACF). http://www.Taacf.org/about-TB-background.htm (accessed 18 January 2010).
7. O'Brien, R. J. Global alliance for TB drug development. Scientific blueprint for TB drug development. Tuberculosis 81, 1-52 (2001).
8. Iwatsuki, M. et al. Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B-0171, have alasso structure. J. Am. Chem. Soc. 128, 7486-7491 (2006).
9. Iwatsuki, M. et al. Lariatins, novel anti-mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-B0171. J. Antibiot. 60, 357-363 (2007).
10. Iwatsuki, M. et al. Lys17 in the 'lasso' peptide lariatin A is responsible for antimycobacterial activity. Bioorg. Med. Chem. Lett. 19, 2888-2890 (2009).
11. Koyama, N. et al. Structure and total synthesis of fungal calpinactam, a new antimycobacterial agent. Org. Lett. 12, 432-435 (2010).
12. Altschul, S. F., Gish, W., Miller, W., Myers, E.W & Lipman, D. J. Basic local alignment search tool. J. Mol. Biol. 215, 403-410 (1990).
13. Cole, S.T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 6685, 515-516 (1998).
14. Siayden, R. A., Lee, R. E. & Barry, C. E. III Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Mol. Microbiol. 38, 514-525 (2000).
15. Takayama, K. & Datte, A. K. Structure-to-function relationship of mycobacterial cell envelope components. Res. Microbiol. 142, 443-448 (1991).
16. Oishi, H. et al. Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties. J. Antibiot. 35, 391-395 (1982).
17. Sasaki, H. et al. Thiolactomycin, a new antibiotic. II. Structure elucidation. J. Antibiot. 35, 396-400 (1982).
18. Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 7091, 358-361 (2006).
19. Wang, J. et al. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proc. Natl Acad. Sci. USA 104, 7612-7616 (2007).
20. Vergne, A. F., Walz, A. J. & Miller, M. J. Iron chelators from mycobacteria (1954-1999) and potential therapeutic applications. Nat. Prod. Rep. 17, 99-116 (2000).
21. Tubaki, K. An illustrated guide to microsporic fungi (Deuteromycetes), collection, isolation and identification (in Japanese) (1998).
22. Jacobson, E., Granville, W. C. & Foss, C. E. Color Harmony Manual 4th edn (Container of America, Chicago, 1958).
23. White, T. J., Bruns, T., Lee, S. & Taylor, J. W. in PCR Protocols: A Guide to Methods and Applications (eds Innis MA, Gelfand RH, Sninsky JJ, White TJ) 315-332 (Academic Press, New York, 1990).